antidiabetic drugs - all trials of antidiabetic drugs by pathology
anti hypertensive agent - all trials of anti hypertensive agent by pathology
cholesterol lowering intervention - all trials of cholesterol lowering intervention by pathology
antiplatelets drug - all trials of antiplatelets drug by pathology
antithrombotics - all trials of antithrombotics by pathology
antioxydants - all trials of antioxydants by pathology
intensive glycemic control - all trials of intensive glycemic control by pathology
screening for CAD - all trials of screening for CAD by pathology
glitazone - all trials of glitazone by pathology
prevention - all trials of prevention by pathology
insulin sensitizer - all trials of insulin sensitizer by pathology
alpha-glucosidase inhibitors - all trials of alpha-glucosidase inhibitors by pathology
insulin secretagogues peptides (incretins) - all trials of insulin secretagogues peptides (incretins) by pathology
antidiabetic drugs added to metformin - all trials of antidiabetic drugs added to metformin by pathology
insulin secretagogues - all trials of insulin secretagogues by pathology
angiotensin-receptor blockers - all trials of angiotensin-receptor blockers by pathology
angiotensin renin system blockade - all trials of angiotensin renin system blockade by pathology
weight-loss drugs - all trials of weight-loss drugs by pathology
intensive therapy - all trials of intensive therapy by pathology

antidiabetic drugs - Access to clinical trials by treatment
anti hypertensive agent - Access to clinical trials by treatment
cholesterol lowering intervention - Access to clinical trials by treatment
antiplatelets drug - Access to clinical trials by treatment
antithrombotics - Access to clinical trials by treatment
antioxydants - Access to clinical trials by treatment
intensive glycemic control - Access to clinical trials by treatment
screening for CAD - Access to clinical trials by treatment
glitazone - Access to clinical trials by treatment
prevention - Access to clinical trials by treatment
insulin sensitizer - Access to clinical trials by treatment
alpha-glucosidase inhibitors - Access to clinical trials by treatment
insulin secretagogues peptides (incretins) - Access to clinical trials by treatment
antidiabetic drugs added to metformin - Access to clinical trials by treatment
insulin secretagogues - Access to clinical trials by treatment
angiotensin-receptor blockers - Access to clinical trials by treatment
angiotensin renin system blockade - Access to clinical trials by treatment
weight-loss drugs - Access to clinical trials by treatment
intensive therapy - Access to clinical trials by treatment

Entry terms: Diabetes Mellitus, Ketosis-Resistant, Diabetes Mellitus, Diabetes Insipidus, Diabetes Mellitus, Type 2, Diabetes Mellitus, Ketosis-Resistant, Diabetes Mellitus, Ketosis Resistant, Ketosis-Resistant Diabetes Mellitus, Diabetes Mellitus, Maturity-Onset, Diabetes Mellitus, Maturity Onset, Diabetes Mellitus, Non Insulin Dependent, Diabetes Mellitus, Non-Insulin-Dependent, Non-Insulin-Dependent Diabetes Mellitus, Type 2 Diabetes Mellitus, Diabetes Mellitus, Slow-Onset, Diabetes Mellitus, Slow Onset, Slow-Onset Diabetes Mellitus, Diabetes Mellitus, Stable, Stable Diabetes Mellitus, Diabetes Mellitus, Type II, Maturity-Onset Diabetes Mellitus, Maturity Onset Diabetes Mellitus, MODY, NIDDM, Diabetes Mellitus, Adult-Onset, Adult-Onset Diabetes Mellitus, Diabetes Mellitus, Adult Onset, Diabetes Mellitus, Noninsulin Dependent, Diabetes Mellitus, Type 1, Diabetes Mellitus, Insulin-Dependent, Diabetes Mellitus, Insulin Dependent, Insulin-Dependent Diabetes Mellitus, Diabetes Mellitus, Juvenile-Onset, Diabetes Mellitus, Juvenile Onset, Juvenile-Onset Diabetes Mellitus, Type 1 Diabetes Mellitus, Diabetes Mellitus, Sudden-Onset, Diabetes Mellitus, Sudden Onset, Mellitus, Sudden-Onset Diabetes, Sudden-Onset Diabetes Mellitus, Diabetes Mellitus, Type I, IDDM, Diabetes Mellitus, Brittle, Brittle Diabetes Mellitus, Diabetes Mellitus, Ketosis-Prone, Diabetes Mellitus, Ketosis Prone, Ketosis-Prone Diabetes Mellitus, Diabetes, Autoimmune, Autoimmune Diabete, Diabete, Autoimmune, Autoimmune Diabetes, Diabetes Complications, Diabetes Complication, Diabetes-Related Complications, Diabetes Related Complications, Diabetes-Related Complication, Diabetic Complications, Diabetic Complication, Complications of Diabetes Mellitus, Diabetes Mellitus Complication, Diabetes Mellitus Complications, Diabetes Insipidus, Neurogenic, Diabetes Insipidus, Neurohypophyseal, Neurohypophyseal Diabetes Insipidus, Diabetes Insipidus, Central, Central Diabetes Insipidus, Diabetes Insipidus, Pituitary, Pituitary Diabetes Insipidus, Neurogenic Diabetes Insipidus, Diabetes Insipidus, Nephrogenic, Nephrogenic Diabetes Insipidus, Nephrogenic Diabetes Insipidus, Type II, Diabetes Insipidus, Nephrogenic, Type II, Nephrogenic Diabetes Insipidus, Type I, Diabetes Insipidus, Nephrogenic, Type I, Acquired Nephrogenic Diabetes Insipidus, Congenital Nephrogenic Diabetes Insipidus, Diabetes Mellitus, Experimental, Experimental Diabetes Mellitus, Streptozotocin Diabetes, Diabetes, Streptozotocin, Streptozocin Diabetes, Diabete, Streptozocin, Diabetes, Streptozocin, Streptozocin Diabete, Alloxan Diabetes, Diabetes, Alloxan, Diabetes, Gestational, Diabetes, Pregnancy-Induced, Diabetes, Pregnancy Induced, Pregnancy-Induced Diabetes, Gestational Diabetes, Diabetes Mellitus, Gestational, Gestational Diabetes Mellitus, National Institute of Diabetes and Digestive and Kidney Diseases (U.S.), NIDDK, National Institute of Diabetes and Digestive and Kidney Diseases, Diabetes Mellitus, Lipoatrophic, Lipoatrophic Diabetes Mellitus, Noninsulin-dependent diabetes mellitus with deafness, Diabetes and deafness, maternally inherited, Diabetes mellitus, type 2, with deafness, Maternally inherited diabetes and deafness, Diabetes-deafness syndrome, maternally transmitted, NIDDM with deafness, Ballinger-Wallace Syndrome, Diabetes insipidus, nephrogenic, X-linked, Diabetes insipidus, nephrogenic, type 1, Pancreatic beta cell agenesis with neonatal diabetes mellitus, Congenital absence of insulin-producing beta cells with diabetes mellitus, AREDYLD Syndrome, Acrorenal field defect, ectodermal dysplasia, and lipoatrophic diabetes, AREDYLD, Acral renal ectodermal dysplasia lipoatrophic diabetes, Achard-Thiers syndrome, Diabetic-bearded woman syndrome, Diabetes in bearded women, Adenoma associated virilism of older women, Bearded female with diabetes, Diabetes insipidus primary central, Diabetes insipidus cranial type, Renal cysts and diabetes syndrome, Maturity-onset diabetes of the young, type 5, Hyperuricemic nephropathy, familial juvenile, atypical, Glomerulocystic kidney disease, hypoplastic type, Glomerulocystic kidney, familial hypoplastic, Rrad protein, rat, Ras-related associated with diabetes protein, rat, Ras associated with diabetes protein, rat, Rad protein, rat, Hypophosphatemia, Familial, Familial Hypophosphatemias, Hypophosphatemias, Familial, Familial Hypophosphatemia, Phosphaturia, Hyperphosphaturia, Phosphate Diabetes, Diabetes, Phosphate, Hemochromatosis, Hemochromatoses, Diabetes, Bronze, Bronze Diabetes, Gestational Diabetes Insipidus, Dipsogenic Diabetes Insipidus, Lipoatrophic diabetes, Lipodystrophy, familial, of limbs and lower trunk, Lipodystrophy, reverse partial, Diabetes mellitus, Addison's disease, myxedema, Polyglandular deficiency syndrome, type 2, Polyglandular autoimmune syndrome, type 2, Autoimmune polyendocrine syndrome, type 2, Multiple endocrine deficiency syndrome, type 2, Berardinelli-Seip congenital lipodystrophy type 2, Brunzell syndrome, Total lipodystrophy and acromegaloid gigantism, Seip syndrome, Berardinelli syndrome, Congenital lipoatrophic diabetes, Fanconi Bickel syndrome, Glycogen storage disease XI, Glycogenosis, Fanconi type, Hepatic glycogenosis with fanconi nephropathy, Hepatorenal glycogenosis with renal Fanconi syndrome, Pseudo-phlorizin diabetes, Fanconi syndrome with intestinal malabsorption and galactose intolerance, Hepatic glycogenosis with amino aciduria and glucosuria, Wolcott-Rallison syndrome, MED-IDDM syndrome, IDDM-MED syndrome, Epiphyseal dysplasia, multiple, with early-onset diabetes mellitus, Yorifuji Okuno syndrome, Pancreatic hypoplasia diabetes heart disease, Lipoatrophy with diabetes, hepatic steatosis, cardiomyopathy, and leukomelanodermic papules

Search Diabetes clinical trials in Pubmed

Search Diabetes clinical trials in ClinicalTrials.gov

Search Diabetes clinical trials in Wikipedia

Search Diabetes in drugs.com

browse_patho2

Keywords
Diabetes trials studies clinical-trials trial-results study-results Diabetes MellitusGlucose Intolerance Diabetes Mellitus, Insulin Dependent Type 1 Diabetes Mellitus IDDM Diabetes Mellitus, Type 2 Diabetes Mellitus, Non Insulin Dependent Type 2 Diabetes Mellitus NIDDM diabetic

This site complies to the HONcode standard for trustworthy health information: verify here.

Last uptaded on 2010/12
28 user(s) connected

TrialResults-center database by TrialResults-center is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 2.0 France License .

OpenSearch feed - Add TrialResults-center.org to your browser's search bar